Welcome visitor Log In - or - Register
(
0 items /
$0.00
)
View Cart
Check Out
four ways
Quick Search:
LXS-196 (NVP-LXS196)
LXS196 (Darovasertib) is an orally bioavailable, potent and selective protein kinase C inhibitor. It is currently in trials for metastatic uveal melanoma.
Catalog NO: CT-LXS196
Synonym: Darovasertib, NVP-LXS196
CAS NO: 1874276-76-2
Mol. Formula: C22H23F3N8O
MW: 472.5
** in vivo Quality Material. 99.9% Pure by HPLC, recrystallized yellow powder (Pic attached). Free base (salt-free), validated by a spot-on quantitative microanalysis. Bulk (get discounted quotes for other sizes)! Prompt.